133 related articles for article (PubMed ID: 25796800)
1. [NLRP3 inflammasome and visceral adipose tissue].
Esser N; Legrand-Poels S; Piette J; Paquot N; Scheen AJ
Rev Med Liege; 2014; 69 Spec No():57-61. PubMed ID: 25796800
[TBL] [Abstract][Full Text] [Related]
2. A Role of the Inflammasome in the Low Storage Capacity of the Abdominal Subcutaneous Adipose Tissue in Obese Adolescents.
Kursawe R; Dixit VD; Scherer PE; Santoro N; Narayan D; Gordillo R; Giannini C; Lopez X; Pierpont B; Nouws J; Shulman GI; Caprio S
Diabetes; 2016 Mar; 65(3):610-8. PubMed ID: 26718495
[TBL] [Abstract][Full Text] [Related]
3. Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue.
Esser N; L'homme L; De Roover A; Kohnen L; Scheen AJ; Moutschen M; Piette J; Legrand-Poels S; Paquot N
Diabetologia; 2013 Nov; 56(11):2487-97. PubMed ID: 24013717
[TBL] [Abstract][Full Text] [Related]
4. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
5. The complex P2X7 receptor/inflammasome in perivascular fat tissue of heavy smokers.
Rossi C; Santini E; Chiarugi M; Salvati A; Comassi M; Vitolo E; Madec S; Solini A
Eur J Clin Invest; 2014; 44(3):295-302. PubMed ID: 24372548
[TBL] [Abstract][Full Text] [Related]
6. Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation.
Honda H; Nagai Y; Matsunaga T; Okamoto N; Watanabe Y; Tsuneyama K; Hayashi H; Fujii I; Ikutani M; Hirai Y; Muraguchi A; Takatsu K
J Leukoc Biol; 2014 Dec; 96(6):1087-100. PubMed ID: 25210146
[TBL] [Abstract][Full Text] [Related]
7. Macrophages control innate inflammation.
Akira S; Misawa T; Satoh T; Saitoh T
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():10-8. PubMed ID: 24003916
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development.
Ahechu P; Zozaya G; Martí P; Hernández-Lizoáin JL; Baixauli J; Unamuno X; Frühbeck G; Catalán V
Front Immunol; 2018; 9():2918. PubMed ID: 30619282
[TBL] [Abstract][Full Text] [Related]
9. Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance.
Henriksbo BD; Lau TC; Cavallari JF; Denou E; Chi W; Lally JS; Crane JD; Duggan BM; Foley KP; Fullerton MD; Tarnopolsky MA; Steinberg GR; Schertzer JD
Diabetes; 2014 Nov; 63(11):3742-7. PubMed ID: 24917577
[TBL] [Abstract][Full Text] [Related]
10. Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family.
Tack CJ; Stienstra R; Joosten LA; Netea MG
Immunol Rev; 2012 Sep; 249(1):239-52. PubMed ID: 22889226
[TBL] [Abstract][Full Text] [Related]
11. The NLRP3 inflammasome regulates adipose tissue metabolism.
Barra NG; Henriksbo BD; Anhê FF; Schertzer JD
Biochem J; 2020 Mar; 477(6):1089-1107. PubMed ID: 32202638
[TBL] [Abstract][Full Text] [Related]
12. Apelin inhibits the activation of the nucleotide-binding domain and the leucine-rich, repeat-containing family, pyrin-containing 3 (NLRP3) inflammasome and ameliorates insulin resistance in severely burned rats.
Chi Y; Chai J; Xu C; Luo H; Zhang Q
Surgery; 2015 Jun; 157(6):1142-52. PubMed ID: 25817096
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity.
Camell CD; Nguyen KY; Jurczak MJ; Christian BE; Shulman GI; Shadel GS; Dixit VD
J Biol Chem; 2015 Dec; 290(49):29402-13. PubMed ID: 26438821
[TBL] [Abstract][Full Text] [Related]
14. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.
Usui F; Shirasuna K; Kimura H; Tatsumi K; Kawashima A; Karasawa T; Yoshimura K; Aoki H; Tsutsui H; Noda T; Sagara J; Taniguchi S; Takahashi M
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):127-36. PubMed ID: 25378412
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 at the interface of metabolism and inflammation.
Haneklaus M; O'Neill LA
Immunol Rev; 2015 May; 265(1):53-62. PubMed ID: 25879283
[TBL] [Abstract][Full Text] [Related]
16. Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders.
Wani K; AlHarthi H; Alghamdi A; Sabico S; Al-Daghri NM
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33435142
[TBL] [Abstract][Full Text] [Related]
17. Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity.
Stienstra R; Stefan N
Diabetologia; 2013 Nov; 56(11):2343-6. PubMed ID: 23995473
[TBL] [Abstract][Full Text] [Related]
18. Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes.
Legrand-Poels S; Esser N; L'homme L; Scheen A; Paquot N; Piette J
Biochem Pharmacol; 2014 Nov; 92(1):131-41. PubMed ID: 25175736
[TBL] [Abstract][Full Text] [Related]
19. Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans.
Goossens GH; Blaak EE; Theunissen R; Duijvestijn AM; Clément K; Tervaert JW; Thewissen MM
Mol Immunol; 2012 Mar; 50(3):142-9. PubMed ID: 22325453
[TBL] [Abstract][Full Text] [Related]
20. Fatty Acids and NLRP3 Inflammasome-Mediated Inflammation in Metabolic Tissues.
Ralston JC; Lyons CL; Kennedy EB; Kirwan AM; Roche HM
Annu Rev Nutr; 2017 Aug; 37():77-102. PubMed ID: 28826373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
